HOME >> BIOLOGY >> NEWS
Stevens professor to speak during Princeton lecture series

Michael S. Bruno, Director of the Center for Maritime Systems and Professor of Ocean Engineering at Stevens Institute of Technology, will present the talk, "Advances in Coastal Ocean Observation Technologies," Saturday February 11, 2006 at 9:30 a.m. at Princeton University's MBG Auditorium. The presentation is part of Princeton Plasma Physics Laboratory's Science on Saturday Lecture Series 2006, a series of talks geared toward high school students but open to all. Princeton Plasma Physics Laboratory is a U.S. Department of Energy Facility.

Since 1998, Stevens has been developing a network of operational coastal ocean and estuary sensors that provide real-time observations of weather and ocean conditions throughout the region. As the network has expanded, and experience has been gained in the operation of the sensors and in the specialized needs of the array of data users, the system has evolved significantly. A forecasting component has been added, and 48-hour forecasts of weather and ocean conditions throughout the region are provided via the Internet, at http://hudson.dl.stevens-tech.edu/NYHOPS/. The Stevens system is now an important tool for the navigation, fishing, emergency management, and first responder communities. It also serves as a test-bed for new ocean observing technologies.

Bruno's presentation will address the technical details of the system, the essential partnering with the user community and the unique challenges associated with constructing an operational ocean observing and forecasting system in an urbanized coastal ocean region. He will also discuss future applications of coastal ocean observing systems to the array of short- and long-term issues confronting our society.

Bruno's research and teaching interests include ocean observation systems, coastal ocean dynamics, maritime security and estuary and ocean water quality. He is the author of more than 80 technical publicat
'"/>

Contact: Stephanie Mannino
smannino@stevens.edu
201-216-5602
Stevens Institute of Technology
10-Feb-2006


Page: 1 2

Related biology news :

1. Stevens and Connecticut Innovations agree to investment of $500,000 in SPOC Inc.
2. Stevens Center for Science Writings honors Edward O. Wilson with Green Book Award
3. Stevens, N.J. Sea Grant to host coastal management workshop
4. Stevens Davidson Laboratory acquires new research vessel
5. Stevens professor named an Early Career Principal Investigator
6. Stevens Disruptive Technologies Roundtable Series discusses SPOC
7. Stevens CSW begins list of 100 Greatest Science Books
8. Stevens and Monmouth Presidents to co-chair ASBPA National Scientific Shore and Beach Conference
9. Lee M. Silver to discuss new book, Challenging Nature, at Stevens
10. Journalists to discuss scientific challenges in Stevens lecture
11. Stevens Professor Alan Blumberg to speak at New York Public Library

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stevens professor speak during Princeton lecture series

(Date:10/16/2014)... conventional thinking on how the bowel lining develops and, ... bowel cancer starts. , The researchers produced evidence that ... ,crypts, that are a feature of the bowel lining, ... cancer development, a controversial finding as scientists are still ... imaging technologies, Dr Chin Wee Tan and Professor Tony ...
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2New perspectives for development of an RSV vaccine 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
(Date:10/22/2014)... BOSTON , Oct. 22, 2014 /PRNewswire/ ... global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, ... option to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, ... agonist, for the treatment of diabetic gastroparesis and other ... a successful Phase 2 trial of relamorelin for the ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider ... with a team of researchers from Yale University’s School ... Collaborative to provide electronic questionnaire data collection through use ... started in May, aims to evaluate the impact of ... to and participation in urban agriculture to impact their ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, announced today ... a Notice of Allowance for a composition of matter ... C. difficile program, SYN-004. This is Synthetic Biologics, ... the U.S. and adds to the Company,s extensive ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
Cached News: